Aurobindo Pharma Ltd is currently trading at Rs. 799, down by Rs. 6.2 or 0.77% from its previous closing of Rs. 805.2 on the BSE.
Aurobindo Pharma Ltd has announced that it has received US FDA approval for Fenofibrate Tablets.
Aurobindo Pharma Ltd is currently trading at Rs. 799, down by Rs. 6.2 or 0.77% from its previous closing of Rs. 805.2 on the BSE.
The scrip opened at Rs. 805 and has touched a high and low of Rs. 807 and Rs. 795.15 respectively. So far 417263(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 47117.86 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 891.5 on 30-Dec-2015 and a 52 week low of Rs. 582 on 25-Feb-2016. Last one week high and low of the scrip stood at Rs. 821.9 and Rs. 756 respectively.
The promoters holding in the company stood at 53.79 % while Institutions and Non-Institutions held 34.67 % and 11.54 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment